Home > Cancer Center > Administration

Funding Opportunities

NCI

NIH Other

AACR 

Additional Funding


NCI

Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 49234
Title: PREVENT Cancer Drug Development Program
E-mail: NCIPREVENT@mail.nih.gov
Web Site: http://dcp.cancer.gov/programs-resources/programs/prevent
Program URL: http://dcp.cancer.gov/files/programs-resources/prevent-program-instructions.pdf

SYNOPSIS:  The PREVENT Cancer Drug Development Program is a National Cancer Institute-supported pipeline to bring new cancer prevention agents and interventions through preclinical development to clinical trials.

Deadline(s):

DEADLINE NOTE
Entry into PREVENT can occur at any stage of the drug development pipeline but depends on favorable review of the application's
scientific merit and the Division of Cancer Prevention's priorities and resources. Submission deadlines occur twice per year in August and February.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?49234


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 27326
Title: RFP -- AMENDMENT -- Preclinical In Vitro and In Vivo Agent Development Assays
E-mail: rf212s@nih.gov
Program URL: https://www.fbo.gov/?s=opportunity&mode=form&id=c520e0fb05060347b989325723b5b49b&tab=core&_cview=0Posted

SYNOPSIS:  A -- PRECLINICAL IN VITRO AND IN VIVO AGENT DEVELOPMENT ASSAYS - PRE SOLICITATION NOTICE   SOL N01CN25001-26 POC

Rukshani Fernnado, Phone: 3014353783,Virginia DeSeau, Phone:
301-435-3978 WEB: FBO.gov Permalink
https://www.fbo.gov/spg/HHS/NIH/FCRF/N01CN25001-26/listing.html

E-MAIL: rf212s@nih.gov, vd9t@nih.gov rf212s@nih.gov, vd9t@nih.gov
NAICS: 541711 Pre Solicitation Please see attached Presoliciation notice.CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=c520e0fb05060347b98932
5723b5b49b&tab=core&_cview=0Posted 02/22/12 (W-SN02680102).

Deadline(s):

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?27326


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 91832
Title: Academic-Industrial Partnerships for Development and Validation of In Vivo Imaging Systems and Methods for Cancer Investigations (R01)
E-mail: bakerhou@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PAR-10-169.html

SYNOPSIS:  The sponsor invites applications from research partnerships formed by academic and industrial investigators to accelerate the translation of either animal or human in vivo imaging, image guided, and/or spectroscopic systems and methods designed to solve targeted cancer problems for cancer research, clinical trials, and/or clinical practice. The partners on each application will establish an inter-disciplinary, multi-institutional research team to work in a strategic alliance to implement a coherent strategy to develop and translate the proposed system or methods with potential for significant impact on preclinical, single, or multisite clinical studies. Partnerships must include at least one lead academic and one lead industrial organization large or small among their numbers. For either preclinical or clinical research, funding may be requested for limited additional copies of prototype systems and methods in order to optimize and validate them across different platforms and/or research sites. Each partnership is encouraged to plan to solve its choice of targeted cancer problem within the five year funding period. This FOA supports clinical trials that emphasize optimization and validation of the performance of imaging systems, including devices, agents and/or methods.  It will not support commercial production. This program will use the NIH Research Project (R01) award mechanism. 

Deadline(s): 05/07/2011
                  06/05/2011
                  09/07/2011
                  10/05/2011
                  01/07/2012
                  02/05/2012
                  05/07/2012
                  06/05/2012
                  09/07/2012
                  10/05/2012
                  01/07/2013
                  02/05/2013
                  05/07/2013

DEADLINE NOTE
The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?91832


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 92792
Title: Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21)
E-mail: yk47s@nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-10-088.html

SYNOPSIS:  The sponsor invites applications for exploratory research on the role of nutrition in cancer prevention. Specifically, this FOA seeks to promote cancer prevention research to identify and characterize molecular targets for bioactive food components. For the purpose of this FOA, a bioactive food component is defined as a dietary constituent that has a health benefit by altering one or more cellular processes when provided in quantities over and beyond that needed for basic nutrition.  This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Deadline(s): 05/07/2011
                  06/16/2011
                  09/07/2011
                  10/16/2011
                  01/07/2012
                  02/16/2012
                  05/07/2012
                  06/16/2012
                  09/07/2012
                  10/16/2012
                  01/07/2013
                  02/16/2013
                  05/07/2013

DEADLINE NOTE
The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?92792


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 49356
Title: National Cancer Institute (NCI) Cancer Education and Career Development Program (R25)
E-mail: myrickd@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PAR-10-165.html

SYNOPSIS:  The sponsor invites applications for the continuation of the Cancer Education and Career Development Program (CECDP) established by the National Cancer Institute (NCI), of the National Institutes of Health (NIH). The purpose of the CECDP is to support the development and implementation of institutional curriculum-dependent predoctoral/postdoctoral programs in the areas of cancer prevention and control, behavioral and population sciences research, nutrition, epidemiology, and/ or biostatistics.  This FOA will use the NIH Research Education (R25) grant mechanism.

Deadline(s): 05/07/2011
                  05/25/2011
                  09/07/2011
                  09/25/2011
                  01/07/2012
                  01/25/2012
                  05/07/2012
                  05/25/2012
                  09/07/2012
                  09/25/2012
                  01/07/2013
                  01/25/2013
                  05/07/2013

DEADLINE NOTE
The deadlines for receipt of standard applications under this announcement are: January 25, May 25, and September 25 annually. The deadlines for receipt of AIDS-related applications are: January 7, May
7, and September 7 annually.   This program expires on May 8, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?49356


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 16329
Title: Biomarkers of Infection-Associated Cancers (R01)
E-mail: kruegerk@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-11-158.html

SYNOPSIS:  The sponsor offers support for research proposals focused on identifying protein biomarkers for cancers where etiology of the disease is attributed to infectious agents.  This program will use the NIH Research Project (R01) award mechanism.

Deadline(s): 06/05/2011
                  09/07/2011
                  10/05/2011
                  01/07/2012
                  02/05/2012
                  05/07/2012
                  06/05/2012
                  09/07/2012
                  10/05/2012
                  01/07/2013
                  02/05/2013
                  05/07/2013
                  06/05/2013
                  09/07/2013
                  10/05/2013
                  01/07/2014
                  02/05/2014
                  05/07/2014

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011.  The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?16329


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 20744
Title: Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01)
E-mail: yk47s@nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-11-160.html

SYNOPSIS:  The sponsor invites applications for research efforts aimed at establishing the physiological significance of dietary components in modulating the tumoricidal cell activity of natural killer (NK) cells for cancer prevention.  This program will use the NIH Research Project (R01) award mechanism.

Deadline(s): 06/05/2011
                  10/05/2013
                  02/05/2014
                  09/07/2013
                  01/07/2014
                  05/07/2014
                  02/05/2013
                  09/07/2011
                  10/05/2011
                  01/07/2012
                  02/05/2012
                  05/07/2012
                  06/05/2012
                  09/07/2012
                  10/05/2012
                  01/07/2013
                  06/05/2013
                  05/07/2013

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011.  The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?20744


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 76042
Title: Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2010, 2011 and 2012 (P50)
E-mail: hechtt@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PAR-10-003.html

SYNOPSIS:  The sponsors invite new or renewal (competing) applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPOREs). The program will fund 5-year P50 SPORE grants to support state-of-the-art investigator-initiated research that will contribute to improved detection, diagnosis, treatment, and prevention of an organ-specific cancer (or a related group of cancers). SPOREs are expected not only to conduct a wide spectrum of research activities, but also to contribute significantly to the development of specialized research COREs, improved research model systems, and collaborative research projects with other institutions. The research supported through this program must be translational in nature and must always be based upon knowledge of human biology stemming from research using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. This FOA will utilize the NIH specialized center grant (P50) mechanism.

Deadline(s): 12/20/2011
                  01/20/2012
                  04/22/2012
                  05/22/2012
                  08/20/2012
                  09/20/2012

DEADLINE NOTE
The deadlines for receipt of optional letters of intent are: December 20, 2011 ; April 22, 2012; and August 20, 2012. The corresponding deadlines for receipt of full applications are: January 20, 2012; May 22, 2012; and September 20, 2012. This program will expire on September 21, 2012.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?76042


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 04579
Title: Image-Guided Drug Delivery in Cancer (R01)
E-mail: tandonp@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-09-253.html

SYNOPSIS:  The sponsor invites applications for innovative translational research in the development of quantitative in vivo
imaging characterization of image-guided drug delivery (IGDD) in cancer, including characterizations of the target, delivery
validation, and therapy response. This FOA will support research in development of integrated imaging-based platforms for multifunctional and multiplexed drug delivery systems in cancer. Validation studies in non-human primates or large animal models and first in human studies directed towards translation of IGDD technology into the clinic will be considered appropriate for this FOA. This FOA will use the NIH Research Project (R01) award mechanism.

Deadline(s): 01/07/2012
                  02/05/2012
                  05/07/2012
                  06/05/2012
                  09/07/2012

DEADLINE NOTE
The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?04579


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 71021
Title: Research on Malignancies in the Context of HIV/AIDS (R01)
E-mail: domingug@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-10-290.html

SYNOPSIS:  The sponsors invite applications from institutions/organizations that propose to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying Human
Immunodeficiency (HIV) infection or Acquired Immune Deficiency Syndrome (AIDS). The NCI and NIDCR seek to encourage research in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both AIDS-defining and non-AIDS defining malignancies in diverse populations in the context of an underlying HIV infection. This FOA invites research efforts that will: (i) provide information on the clinical outcomes of such cancers in the HIV-infected population; and (ii) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers. This program will use the NIH Research Project (R01) award mechanism. 

Deadline(s): 01/07/2012
                  05/07/2012
                  09/07/2012
                  01/07/2013
                  05/07/2013
                  09/07/2013

DEADLINE NOTE
This program will expire on September 8, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?71021


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 87651
Title: Research on Malignancies in the Context of HIV/AIDS (R21)
E-mail: dominguag@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-10-291.html

SYNOPSIS:   The sponsors invite applications from institutions/ organizations that propose to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying Human Immunodeficiency (HIV) infection or Acquired Immune Deficiency Syndrome (AIDS). The NCI and NIDCR seek to encourage research in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both AIDS-defining and non-AIDS defining malignancies in diverse populations in the context of an underlying HIV infection. This FOA invites research efforts that will: (i) provide information on the clinical outcomes of such cancers in the HIV-infected population; and (ii) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Deadline(s): 01/07/2012
                  05/07/2012
                  09/07/2012
                  01/07/2013
                  05/07/2013
                  09/07/2013

DEADLINE NOTE
This program will expire on September 8, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?87651


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 99326
Title: Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21)
E-mail: tricolij@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-08-267.html

SYNOPSIS:  The sponsor provides support for applications from institutions and organizations that are interested in developing and testing innovative methods in cancer detection, diagnosis, and prognosis. The NCI is especially interested in research studies that focus on the development and testing of improved methods for detecting specific characteristics of cancer, which can be subsequently used for the clinical management of cancer patients or individuals who are at risk for (developing) cancer. It is important that research studies focus on the search for molecular and cellular differences between tumors, pre-malignant, or normal tissues. The studies should determine the clinical translational significance of these differences by correlation with clinical parameters, in order to answer clinical problems related to detection, diagnosis, treatment, and prognosis. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Deadline(s): 01/07/2012
                  02/16/2012
                  05/07/2012
                  06/16/2012
                  09/07/2012

DEADLINE NOTE
The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?99326


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 05909
Title: Epigenetic Approaches in Cancer Epidemiology (R01)
E-mail: vermam@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-10-031.html

SYNOPSIS:  The sponsor invites research applications that proposeto evaluate profiles of methylation, histone modifications and microRNA (miRNA) and their association with risk of developing cancer in different populations. The overarching goal of this FOA is to provide support for population based studies to define the role of epigenetic markers (methylation, histone and micro RNA profiles) changes to understand cancer etiology. This program will use the NIH Research Project (R01) award mechanism.

Deadline(s): 01/07/2012
                  02/05/2012
                  05/07/2012
                  06/05/2012
                  09/07/2012
                  10/05/2012
                  01/07/2013

DEADLINE NOTE
The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?05909


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 05914
Title: Epigenetic Approaches in Cancer Epidemiology (R21)
E-mail: vermam@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-10-032.html

SYNOPSIS:  The sponsor invites research applications that propose to evaluate profiles of methylation, histone modifications and microRNA (miRNA) and their association with risk of developing cancer in different populations. The overarching goal of this FOA is to provide support for population based studies to define the role of epigenetic markers (methylation, histone and micro RNA profiles) changes to understand cancer etiology. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. 

Deadline(s): 01/07/2012
                  02/16/2012
                  05/07/2012
                  06/16/2012
                  09/07/2012
                  10/16/2012
                  01/07/2013

DEADLINE NOTE
The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?05914


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 90756
Title: Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) 
E-mail: freedmaa@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-10-026.html

SYNOPSIS:   The sponsor invites research applications  from clinicians, epidemiologists, geneticists, statisticians, and translational researchers working in the field of cancer control and prevention to improve existing models for cancer risk and prognosis by developing innovative research projects that use existing data; develop new models for cancer risk and prognosis; and validate new models and evaluate their utility in research and clinic settings. To explore this opportunity, the NCI Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Treatment and Diagnosis (DCTD) encourage applications for research projects to develop, apply, and evaluate new and existing cancer risk and prognostic prediction models for use by researchers, clinicians, and the general public. This FOA is designed to provide a mechanism of support for investigators to address two major challenges in model development, which are: integrating diverse types of data (e.g., clinical, demographic, pathologic, environmental, epidemiologic, outcomes, and genetic data from varied data marts or warehouses); and
ensuring adequate validation (i.e., using multiple separate populations to define sensitivity, specificity, and positive and negative predictive values). This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Deadline(s): 01/07/2012
                  02/16/2012
                  05/07/2012
                  06/16/2012
                  09/07/2012
                  10/16/2012
                  01/07/2013

DEADLINE NOTE
The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?90756


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 90931
Title: Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01)
E-mail: freedmaa@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-10-025.html

SYNOPSIS:  The sponsor invites research applications  from clinicians, epidemiologists, geneticists, statisticians, and translational researchers working in the field of cancer control and prevention to improve existing models for cancer risk and prognosis by developing innovative research projects that use existing data; develop new models for cancer risk and prognosis; and validate new models and evaluate their utility in research and clinic settings. To explore this opportunity, the NCI Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Treatment and Diagnosis (DCTD) encourage applications for research projects to develop, apply, and evaluate new and existing cancer risk and prognostic prediction models for use by researchers, clinicians, and the general public. This FOA is designed to provide a mechanism of support for investigators to address two major challenges in model development, which are: integrating diverse types of data (e.g., clinical, demographic, pathologic, environmental, epidemiologic, outcomes, and genetic data from varied data marts or warehouses); and ensuring adequate validation (i.e., using multiple separate populations to define sensitivity, specificity, and positive and negative predictive values). This program will use the NIH Research Project (R01) award mechanism. 

Deadline(s): 01/07/2012
                  02/05/2012
                  05/07/2012
                  06/05/2012
                  09/07/2012
                  10/05/2012
                  01/07/2013

DEADLINE NOTE
The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?90931


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 91013
Title: Prioritizing Molecular Targets for Cancer Prevention with Nutritional Combinations (R01) 
E-mail: davisci@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-10-035.html

SYNOPSIS:  The sponsor invites research applications to enhance our understanding about the dynamic interrelationship that exists between bioactive food components (and/or combinations thereof) and cancer prevention. Although much evidence exists that dietary components are linked to cancer prevention, the interactions among dietary bioactive compounds and food combinations remains under-investigated. Applications are encouraged to consider either multiple dietary bioactive components, intact foods or multiple foods utilizing physiologically relevant concentrations of the agents. New genetic technologies may be employed to study the impact of dietary components on complex cellular and molecular networks, as part of the effort to better understand the basis for the multifaceted interactions of food components with cancer prevention mechanisms.
Specifically, applications that apply new high-throughput genomic, epigenomic, proteomic, and metabolomic technologies to prioritize molecular targets of dietary components are highly encouraged. The sites of action that may be evaluated include carcinogen metabolism, DNA repair, cell proliferation, apoptosis, differentiation, hormonal regulation, energetics, inflammation, and/or angiogenesis. In addition, applications should either evaluate multiple molecular targets within a cancer process or multiple processes in order to prioritize which process(es) is/are most involved in bringing about a phenotypic change. It is hoped that advances in this area may assist in optimizing cancer prevention while minimizing potential toxicity due to food components. The resulting information will help define which foods or food components should be considered in isolation or in combination when developing dietary strategies to reduce cancer risk and/or modify tumor behavior.  This program will use the NIH Research Project (R01) award mechanism. 

Deadline(s): 01/07/2012
                  02/05/2012
                  05/07/2012
                  06/05/2012
                  09/07/2012
                  10/05/2012
                  01/07/2013

DEADLINE NOTE
The deadlines for receipt of standard applications under this announcement are: February 05, June 05, and October 05 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?91013


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 45115
Title: Short-Term Scientist Exchange Program
E-mail: ncioia@mail.nih.gov
Web Site: http://oia.cancer.gov/Programs/Exchange/Pages/programs-exchange.aspx
Program URL: http://oia.cancer.gov/Programs/Exchange/Pages/program-exchange-short.aspx

SYNOPSIS:  The sponsor provides support for collaborative cancer research between established U.S. and foreign scientists from developing countries.  Eligible candidates must have a minimum of three years postdoctoral experience in cancer research and have an invitation from a qualified sponsor.  Cost sharing is required.

Deadline(s): 02/01/2012
                  05/01/2012
                  08/01/2012
                  11/01/2012

DEADLINE NOTE
Applications are accepted throughout the year, with application deadlines of February 1, May 1, August 1, and November 1.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?45115


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 98141
Title: Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01)
E-mail: nordstrr@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PAR-11-150.html

SYNOPSIS:  The sponsor provides support for research on quantitative imaging of tumor response to cancer therapies in clinical trial settings, with the overall goal of facilitating clinical decision making.  Proposed projects should include the appropriate development and adaptation/implementation of quantitative imaging methods, protocols and software solutions/tools (using existing commercial imaging platforms and instrumentation), and their application in current and planned Phase 1-2 clinical therapy trials.

The proposed projects must focus on imaging-derived quantitative measurements of responses to drugs and/or radiation therapy, and/or image-guided interventions.  It is anticipated that these research goals will require multidisciplinary efforts. Therefore, this FOA solicits applications from multi-disciplinary teams to include oncologists as well as clinical and basic imaging scientists.  The involvement of industrial partners in the development of the quantitative imaging methods is not required, but is strongly encouraged.  Awardees will form a Quantitative Imaging Network (QIN) to share ideas and approaches to validate and standardize imaging data and related imaging metadata for quantitative measurements of responses to cancer therapies. This FOA will utilize the NIH U01 cooperative agreement mechanism.

Deadline(s): 02/05/2012
                  06/05/2012
                  10/05/2012
                  02/05/2013
                  06/05/2013
                  10/05/2013
                  02/05/2014
                  06/05/2011
                  10/05/2011

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011.  The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually.  This FOA will expire on May 8, 1014.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?98141


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 72509
Title: Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R01)
E-mail: thurinm@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-12-013.html

SYNOPSIS:  This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) encourages the submission of Research Project Grant (R01) applications from institutions and organizations to validate the clinical utility of new molecular diagnostics for determining prognosis or predicting response to therapy or toxicity for cancer. The Cancer Diagnosis Program (CDP) and the Cancer Therapy Evaluation Program (CTEP) at the NCI are cooperatively sponsoring this FOA with the purpose to transition of candidate biomarkers from initial correlative observations into diagnostics that are suitable for use in clinical trials to assess the clinical validity of a marker. This program will support research projects to improve clinical decision-making in the care of cancer patients and as such will support studies that use tumor specimens linked to specific treatment and clinical outcome information. This FOA is not appropriate for molecular diagnostics discovery projects. This program will use the NIH Research Project (R01) award mechanism.

Deadline(s): 02/05/2012
                  05/07/2012
                  06/05/2012
                  09/07/2012
                  10/05/2012
                  01/07/2013
                  02/05/2013
                  05/07/2013
                  06/05/2013
                  09/07/2013
                  10/05/2013
                  01/07/2014
                  02/05/2014
                  05/07/2014
                  06/05/2014
                  09/07/2014
                  10/05/2014
                  01/07/2015

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012.  The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January  8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?72509


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 26358
Title: Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) 
E-mail: perkinsu@mail.nih.gov
Program URL: http://grants.nih.gov/grants/guide/pa-files/PAR-12-067.html

SYNOPSIS:  National Cancer Institute (NCI) invites applications for the Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award. The award is intended to support the career development of junior investigators with research or health professional doctoral degrees who want to become cancer-focused academic researchers in cancer prevention, cancer control, or the behavioral or population sciences.  This FOA will utilize the NIH Academic Career Award (K07) mechanism. 

Deadline(s): 02/12/2012
                  05/07/2012
                  06/12/2012
                  09/07/2012
                  10/12/2012
                  01/07/2013
                  02/12/2013
                  05/07/2013
                  06/12/2013
                  09/07/2013
                  10/12/2013
                  01/07/2014
                  02/12/2014
                  05/07/2014
                  06/12/2014
                  09/07/2014
                  10/12/2014
                  01/07/2015

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?26358


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 26221
Title: NCI Mentored Research Scientist Development Award to Promote Diversity (K01)
E-mail: ojeifojo@mail.nih.gov
Program URL: http://grants.nih.gov/grants/guide/pa-files/PAR-12-050.html

SYNOPSIS:  National Cancer Institute (NCI) invites applications for the Mentored Research Scientist Development Award (K01)to provide support and ?protected time? (three, four, or five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence.
This Funding Opportunity Announcement (FOA) will utilize the NIH Mentored Research Scientist Development Award (K01) mechanism.

Deadline(s): 02/12/2012
                  05/07/2012
                  06/12/2012
                  09/07/2012
                  10/12/2012
                  01/07/2013
                  02/12/2013
                  05/07/2013
                  06/12/2013
                  09/07/2013
                  10/12/2013
                  01/07/2014
                  02/12/2014
                  05/07/2014
                  06/12/2014
                  09/07/2014
                  10/12/2014
                  01/07/2015

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012.  The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?26221


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 26222
Title: NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08)
E-mail: ojeifojo@mail.nih.gov
Program URL: http://grants.nih.gov/grants/guide/pa-files/PAR-12-051.html

SYNOPSIS:  National Cancer Institute (NCI) invites applications for the NCI Mentored Clinical Scientist Research Career Development Awards (K08). The primary purpose to support and protected time to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.
This NCI-sponsored K08 award is specifically designed to promote career development of clinical scientists from diverse backgrounds that have been shown to be underrepresented in health-related science and for those who are committed to a career in  basic biomedical, behavioral or translational cancer research, including research on cancer health disparities. This Funding Opportunity Announcement (FOA) will utilize the NIH K08 Clinical Investigator Award (CIA) mechanism. 

Deadline(s): 02/12/2012
                  05/07/2012
                  06/12/2012
                  09/07/2012
                  10/12/2012
                  01/07/2013
                  02/12/2013
                  05/07/2013
                  06/12/2013
                  09/07/2013
                  10/12/2013
                  01/07/2014
                  02/12/2014
                  05/07/2014
                  06/12/2014
                  09/07/2014
                  10/12/2014
                  01/07/2015

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012.  The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?26222


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 26223
Title: NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23)
E-mail: ojeifojo@mail.nih.gov
Program URL: http://grants.nih.gov/grants/guide/pa-files/PAR-12-052.html

SYNOPSIS:  National Cancer Institute (NCI) invites applications for the NIH Mentored Patient-Oriented Research Career Development Award (K23). The primary purpose is to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented cancer research.  This Funding Opportunity Announcement (FOA) will utilize the NIH K23 Mentored Patient-Oriented Research Career Development Award mechanism.

Deadline(s): 02/12/2012
                  05/07/2012
                  06/12/2012
                  09/07/2012
                  10/12/2012
                  01/07/2013
                  02/12/2013
                  05/07/2013
                  06/12/2013
                  09/07/2013
                  10/12/2013
                  01/07/2014
                  02/12/2014
                  05/07/2014
                  06/12/2014
                  09/07/2014
                  10/12/2014
                  01/07/2015

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012.  The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?26223


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 26296
Title: NCI Established Investigator Award in Cancer Prevention and Control (K05)
E-mail: lemrows@mail.nih.gov
Program URL: http://grants.nih.gov/grants/guide/pa-files/PAR-12-065.html

SYNOPSIS:  The NCI Established Investigator Award (K05) provides qualified cancer prevention, control, behavioral, and/or population scientists with protected time to devote to research and to mentoring new investigators. This FOA will utilize the NIH Senior Scientist Award (K05) mechanism.

Deadline(s): 02/12/2012
                  05/07/2012
                  06/12/2012
                  09/07/2012
                  10/12/2012
                  01/07/2013
                  02/12/2013
                  05/07/2013
                  06/12/2013
                  09/07/2013
                  10/12/2013
                  01/07/2014
                  02/12/2014
                  05/07/2014
                  06/12/2014
                  09/07/2014
                  10/12/2014
                  01/07/2015

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?26296


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 87502
Title: Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R21)
E-mail: thurinm@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-12-014.html

SYNOPSIS:  This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) encourages the submission of Research Project Grant (R01) applications from institutions and organizations to validate the clinical utility of new molecular diagnostics for determining prognosis or predicting response to therapy or toxicity for cancer. The Cancer Diagnosis Program (CDP) and the Cancer Therapy Evaluation Program (CTEP) at the NCI are cooperatively sponsoring this FOA with the purpose to transition of candidate biomarkers from initial correlative observations into diagnostics that are suitable for use in clinical trials to assess the clinical validity of a marker. This program will support research projects to improve clinical decision-making in the care of cancer patients and as such will support studies that use tumor specimens linked to specific treatment and clinical outcome information.  This program will use the NIH Exploratory/Developmental (R21) grant mechanism.  

Deadline(s): 02/16/2012
                  05/07/2012
                  06/16/2012
                  09/07/2012
                  10/16/2012
                  01/07/2013
                  02/16/2013
                  05/07/2013
                  06/16/2013
                  09/07/2013
                  10/16/2013
                  01/07/2014
                  02/16/2014
                  05/07/2014
                  06/16/2014
                  09/07/2014
                  10/16/2014
                  01/07/2015

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012.  The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January  8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?87502


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 11771
Title: Small Business Technology Transfer Program
E-mail: weingartenm@mail.nih.gov
Web Site: http://grants.nih.gov/grants/guide/pa-files/PA-12-088.html
Program URL: http://grants.nih.gov/grants/funding/sbirsttr1/2012-2_SBIR-STTR-topics.doc

SYNOPSIS:   The sponsor invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications  for therapeutic agents and devices, in vitro diagnostics, imaging, cancer prevention, cancer biology, cancer control and epidemiology, and e-Health. United States SBCs that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics (see PHS 2012-2 SBIR/STTR Program Descriptions and
Research Topics for NIH.).   This FOA will utilize the NIH R41/R42 Small Business Technology Transfer (STTR) Grant - Phase I, Phase II, and Fast-Track award mechanisms. 

Deadline(s): 04/05/2012
                  05/07/2012
                  08/05/2012
                  09/07/2012
                  12/05/2012
                  01/07/2013

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after March 5, 2012. The deadlines for receipt of standard applications under this announcement are: April 5, August 5 and December 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?11771


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 24826
Title: Interventions for Health Promotion and Disease Prevention in Native American Populations (R01)
E-mail: 
Sriniva2@mail.nih.gov 
Program URL: 
http://grants1.nih.gov/grants/guide/pa-files/PAR-11-346.html

SYNOPSIS: The sponsors invite applications to develop, adapt, and test the effectiveness of health promotion and disease prevention interventions in Native American (NA) populations. NA populations are exposed to considerable risk factors that significantly increase their likelihood of chronic disease, substance abuse, mental illness, and HIV-infection. The intervention program should be culturally appropriate and promote the adoption of healthy lifestyles, improve behaviors and social conditions and/or improve environmental conditions related to chronic disease, the consumption of tobacco, alcohol and other drugs, mental illness or HIV-infection. The intervention program should be designed so that it could be sustained within the entire community within existing resources, and, if successful, disseminated in other Native American communities.  This FOA will use the NIH Research Project (R01) award mechanism.

Deadline(s): 04/15/2012
                  05/15/2012
                  04/15/2013
                  05/15/2013
                  04/15/2014
                  05/15/2014

DEADLINE NOTE

Applications may be submitted to Grants.gov in response to this announcement on or after April 15, 2012. The deadline for receipt of optional letters of intent is April 15 annually. The deadline for receipt of full applications is May 15 annually.  This FOA will expire on May 16, 2014.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?24826


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 20887
Title: Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R01)
E-mail: vermam@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-11-073.html

SYNOPSIS:  The sponsor invites applications that propose to develop and validate new mitochondrial-related biomarkers for cancer early detection, diagnosis, prognosis, risk assessment, and response to preventive and ameliorative treatments.  This program will use the NIH Research Project (R01) award mechanism.

Deadline(s): 05/07/2012
                  06/05/2012
                  09/07/2012
                  10/05/2012
                  01/07/2013
                  02/05/2013
                  05/07/2013
                  06/05/2013
                  09/07/2013
                  10/05/2013
                  01/07/2014

DEADLINE NOTE
The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?20887


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 20894
Title: Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21)
E-mail: vermam@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-11-074.html

SYNOPSIS:  The sponsor invites applications that propose to develop and validate new mitochondrial-related biomarkers for cancer early detection, diagnosis, prognosis, risk assessment, and response to preventive and ameliorative treatments.   This program will use the NIH Research Project (R21) award mechanism.

Deadline(s): 05/07/2012
                  06/16/2012
                  09/07/2012
                  10/16/2012
                  01/07/2013
                  02/16/2013
                  05/07/2013
                  06/16/2013
                  09/07/2013
                  10/16/2013
                  01/07/2014

DEADLINE NOTE
The deadlines for receipt of standard R21 applications under this announcement are: June 16, October 16, and February 16 annually.  The deadlines for AIDS and AIDS-related applications are: May 7, September 7, and January 7 annually.  This program will expire on January 8, 2014. 

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?20894


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 53304
Title: Cancer Prevention Research Small Grant Program (R03)
E-mail: LynnS@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PAR-11-079.html

SYNOPSIS:  The sponsor invites applications that propose small and time-limited projects pertinent to the development of cancer
chemoprevention agents, biomarkers for early cancer detection, cancer-related nutrition science, and/or clinical prevention studies
that focus on specific target organs.  Proposed projects may involve basic and/or translational research and/or human subjects-oriented research. However, treatment-related quality-of-life population-based studies, as well as projects focused on cancer etiology, metastasis, or treatment will be considered non-responsive to this FOA. New, as well as established, investigators in relevant fields and disciplines (e.g., chemoprevention, nutritional science, genetics, infectious agents, and early detection, including biomarker development and validation) are encouraged to apply for these small grants to test the feasibility of innovative ideas or carry out pilot studies. Ultimately, these small grants are expected to facilitate the development of full research projects.  This program will use the NIH Small Research Grant (R03) award mechanism. 

Deadline(s): 07/18/2012
                  12/14/2012
                  02/15/2013
                  07/19/2013
                  12/16/2013

DEADLINE NOTE
This program will expire on December 17, 2013.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?53304


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 49234
Title: PREVENT Cancer Drug Development Program
E-mail: NCIPREVENT@mail.nih.gov
Web Site: http://dcp.cancer.gov/programs-resources/programs/prevent
Program URL: http://dcp.cancer.gov/files/programs-resources/prevent-program-instructions.pdf

SYNOPSIS:  The PREVENT Cancer Drug Development Program is a National Cancer Institute-supported pipeline to bring new cancer prevention agents and interventions through preclinical development to clinical trials.

Deadline(s): 10/01/2012
                  04/01/2013

DEADLINE NOTE
Entry into PREVENT can occur at any stage of the drug development pipeline but depends on favorable review of the application's scientific merit and the Division of Cancer Prevention's priorities and resources. Submission deadlines occur twice per year on the first Monday in October and April.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?49234


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 02587
Title: Biomarkers for Early Detection of Hematopoiietic Malignancies (R01)
E-mail: lynns@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-12-221.html

SYNOPSIS:  This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research grant applications from institutions/organizations for the development and validation of biomarkers for: a) early detection, prediction of progression, and recurrence of hematopoietic malignancies, especially in high-risk individuals; and, b) for risk assessment of primary and secondary hematopoietic malignancies. This FOA is also encourages the development and improvement of specific technologies and methods for quantitative detection of novel biomarkers associated with hematopoietic malignancies.  This FOA uses the NIH research project R01 grant mechanism and runs in parallel with an FOA of identical scientific scope, PA-12-220 that encourages applications under the NIH Exploratory/Developmental (R21) Grant mechanism. 

Deadline(s): 10/05/2012
                  01/07/2013
                  02/05/2013
                  05/07/2013
                  06/05/2013
                  09/07/2013
                  10/05/2013
                  01/07/2014
                  02/05/2014
                  05/07/2014
                  06/05/2014
                  09/07/2014
                  10/05/2014
                  01/07/2015
                  02/05/2015
                  05/07/2015
                  06/05/2015
                  09/07/2015

DEADLINE NOTE
The earliest submission date is September 5, 2012. This program will expire on September 8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?02587


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 02626
Title: Biomarkers for Early Detection of Hematopoietic Malignancies (R21)
E-mail: lynns@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-12-220.html

SYNOPSIS:  This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research grant applications from institutions/organizations for the development and validation of biomarkers for: a) early detection, prediction of progression, and recurrence of hematopoietic malignancies, especially in high-risk individuals; and, b) for risk assessment of primary and secondary hematopoietic malignancies. This FOA is also encourages the development and improvement of specific technologies and methods for quantitative detection of novel biomarkers associated with hematopoietic malignancies.  This FOA will utilize the NIH exploratory/developmental (R21) grant mechanism and runs in parallel an FOA of identical scientific scope, PA-12-221, that encourages applications under the R01 mechanism.

Deadline(s): 10/16/2012
                  01/07/2013
                  02/16/2013
                  05/07/2013
                  06/16/2013
                  09/07/2013
                  10/16/2013
                  01/07/2014
                  02/16/2014
                  05/07/2014
                  06/16/2014
                  09/07/2014
                  10/16/2014
                  01/07/2015
                  02/16/2015
                  05/07/2015
                  06/16/2015
                  09/07/2015

DEADLINE NOTE
The earliest submission date is September 16, 2012. This program will expire on September 8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?02626


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 16444
Title: Biomarkers of Infection-Associated Cancers (R21)
E-mail: kruegerk@mail.nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-11-159.html

SYNOPSIS:  The sponsor offers support for research proposals focused on identifying protein biomarkers for cancers where etiology of the disease is attributed to infectious agents. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Deadline(s): 01/07/2013
                  05/07/2012
                  01/07/2014
                  02/16/2014
                  09/07/2011
                  10/16/2011
                  01/07/2012
                  02/16/2012
                  09/07/2012
                  10/16/2012
                  02/16/2013
                  06/05/2013
                  09/07/2013
                  10/16/2013
                  05/07/2014
                  05/07/2013
                  06/16/2011
                  06/16/2012

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2011.  The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?16444


Sponsor: National Cancer Institute/NIH/DHHS
Program Number: 20999
Title: Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R21)
E-mail: yk47s@nih.gov
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-11-161.html

SYNOPSIS:  The sponsor invites applications for research efforts aimed at establishing the physiological significance of dietary components in modulating the tumoricidal cell activity of natural killer (NK) cells for cancer prevention.  This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Deadline(s): 09/07/2013
                  06/16/2013
                  10/16/2013
                  01/07/2014
                  02/16/2014
                  06/16/2011
                  09/07/2011
                  10/16/2011
                  01/07/2012
                  02/16/2012
                  05/07/2012
                  06/16/2012
                  09/07/2012
                  10/05/2012
                  01/07/2013
                  02/16/2013
                  05/07/2013
                  05/07/2014

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2011.  The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?20999

Top of Page


NIH Other

Sponsor: National Institute on Aging/NIH/DHHS
Program Number: 98216
Title: Translational Research at the Aging/Cancer Interface (TRACI) (R01)
E-mail: nayfiels@mail.nih.gov
Program URL: http://grants.nih.gov/grants/guide/pa-files/PA-12-136.html

SYNOPSIS:  >National Institute on Aging (NIA)and National Cancer Institute (NCI) invite applications for translational research proposals in the overlapping areas of human aging and cancer, linking basic and clinical research relevant to the care of older cancer patients through both bench-to-bedside and bedside-to-bench approaches. Ultimately, information from the research supported by this initiative should improve the health and well-being of elderly patients at risk for, or diagnosed with, cancer and decrease the functional impairment and morbidity associated with cancer in this population.  This program will use the NIH Research Project (R01) award mechanism.

Deadline(s): 06/05/2012
                  09/07/2012
                  10/05/2012
                  01/07/2013
                  02/05/2013
                  05/07/2013
                  06/05/2013
                  09/07/2013
                  10/05/2013
                  01/07/2014
                  02/05/2014
                  05/07/2014
                  06/05/2014
                  09/07/2014
                  10/05/2014
                  01/07/2015
                  02/05/2015
                  05/07/2015

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012.  The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?98216


Sponsor: National Institute on Aging/NIH/DHHS
Program Number: 98218
Title: Translational Research at the Aging/Cancer Interface (TRACI) (R21)
E-mail: eldadahb@nia.nih.gov
Program URL: http://grants.nih.gov/grants/guide/pa-files/PA-12-135.html

SYNOPSIS:  National Institute on Aging (NIA)and National Cancer Institute (NCI) invite applications for translational research proposals in the overlapping areas of human aging and cancer, linking basic and clinical research relevant to the care of older cancer patients through both bench-to-bedside and bedside-to-bench approaches. Ultimately, information from the research supported by this initiative should improve the health and well-being of elderly patients at risk for, or diagnosed with, cancer and decrease the functional impairment and morbidity associated with cancer in this population. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. 

Deadline(s): 06/16/2012
                  09/07/2012
                  10/16/2012
                  01/07/2013
                  02/16/2013
                  05/07/2013
                  06/16/2013
                  09/07/2013
                  10/16/2013
                  01/07/2014
                  02/16/2014
                  05/07/2014
                  06/16/2014
                  09/07/2014
                  10/16/2014
                  01/07/2015
                  02/16/2015
                  05/07/2015

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012.  The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?98218


Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS
Program Number: 87411
Title: Mechanisms of Alcohol-associated Cancers (R21)
E-mail: jungma@mail.nih.gov
Program URL: http://grants.nih.gov/grants/guide/pa-files/PA-12-147.html

SYNOPSIS:  National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Cancer Institute (NCI) invite applications from researchers with broad ranges of expertise to study the mechanisms by which alcohol increases cancer risk.  This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Deadline(s): 06/16/2012
                  09/07/2012
                  10/16/2012
                  01/07/2013
                  02/16/2013
                  05/07/2013
                  06/16/2013
                  09/07/2013
                  10/16/2013
                  01/07/2014
                  02/16/2014
                  05/07/2014
                  06/16/2014
                  09/07/2014
                  10/16/2014
                  01/07/2015
                  02/16/2015
                  05/07/2015
                  06/16/2015
                  09/07/2015

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012.  The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2015.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?87411

Top of Page


AACR

Top of Page


Additional Funding

Sponsor: Pardee (Elsa U.) Foundation
Program Number: 00125
Title: Research Grants
E-mail: 
dougherty@pardeefoundation.org
Program URL: http://www.pardeefoundation.org/grants.aspx

SYNOPSIS:  The sponsor funds research to investigators in the United States non-profit institutions proposing research directed towards identifying new treatments or cures for cancer.

Deadline(s):

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?00125


Sponsor: National Brain Tumor Society
Program Number: 00753
Title: Innovation Research Grants
E-mail: ctreadwell@braintumor.org
Program URL: http://www.braintumor.org/research/funding-opportunities/

SYNOPSIS:  The sponsor seeks Letters of Intent (LOI) for transformative or catalytic scientific research projects that will significantly move the field forward toward effective brain tumor therapies.

Deadline(s):

DEADLINE NOTE
Letters of Intent are accepted on a rolling basis and are reviewed on a quarterly basis.  Full applications will be invited by the sponsor.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?00753


Sponsor: Coleman Foundation
Program Number: 04215
Title: Cancer Research
E-mail: info@colemanfoundation.org
Web Site: http://www.colemanfoundation.org/what_we_fund.html
Program URL: http://www.colemanfoundation.org/cancer.html

SYNOPSIS:  The sponsor provides support for specific health care programs, community-based and psychosocial support services, cancer research, development of new treatments, and improvement of direct patient services.

Deadline(s):

DEADLINE NOTE
 Organizations wishing to submit a request may contact the sponsor through a concise letter of inquiry. Full grant proposals should only be submitted upon invitation by the sponsor.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?04215


Sponsor: Tobacco-Related Disease Research Program
Program Number: 24558
Title: Special Projects -- Infrastructure Awards
E-mail: trdrp@ucop.edu
Web Site: http://www.trdrp.org
Program URL: http://www.trdrp.org/fundingOpps/call.php

SYNOPSIS:  The sponsor invites applications for funding designed to support electronic, biological, clinical, and informational support systems that would serve as a resource for tobacco-related disease researchers in the state of California and nationally.

Deadline(s):

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?24558


Sponsor: Susan G. Komen for the Cure Greater New York City
Program Number: 98323
Title: Small Grants Program
E-mail: grants@komennyc.org
Web Site: http://www.komennyc.org/site/PageServer?pagename=grants_overview
Program URL: http://www.komennyc.org/site/PageServer?pagename=grants_small_grants_program

SYNOPSIS:  The sponsor offers small grants of up to $5,000 to support small programs and pilot projects in breast health.

Deadline(s):

DEADLINE NOTE
Komen Greater NYC will consider Small Grants applications three times a year. Award notifications are generally made within six to eight weeks after the deadline. The next application deadline is TBA.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?98323


Sponsor: Shriver (Liddy) Sarcoma Initiative
Program Number: 02288
Title: Research Grants Program
E-mail: info@sarcomahelp.org
Program URL: http://sarcomahelp.org/research_center/sarcoma_research_grants.html

SYNOPSIS:  The Liddy Shriver Sarcoma Initiative funds research that is targeted at finding a cure for sarcoma, as well as research that attempts to develop more effective treatment regimens than those currently available.

Deadline(s):

DEADLINE NOTE
Study proposals are accepted throughout the year. If you are interested in submitting a research proposal, please contact us and request a Grant Application Form.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?02288


Sponsor: National Brain Tumor Society
Program Number: 26772
Title: Innovation Research Grants
E-mail: ctreadwell@braintumor.org
Web Site: http://www.braintumor.org/assets/docs/innovation_grant_letter_of_intent.pdf
Program URL: http://www.braintumor.org/research/funding-opportunities/

SYNOPSIS:  National Brain Tumor Society seeks Letters of Intent (LOI) for transformative or catalytic scientific research projects that will significantly move the field forward toward effective brain tumor therapies. Innovation Grants respond to the brain tumor community?s need for a rapid review process to support highly innovative research projects including those that are ?out-of-the-box.?

Deadline(s):

DEADLINE NOTE
NBTS accepts Innovation Grant Letters of Intent on a rolling basis.
NBTS will review Innovation Grant Letters of Intent on a quarterly basis.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?26772


Sponsor: Gateway for Cancer Research
Program Number: 94369
Title: Research Grant
E-mail:
Web Site: http://www.demandcurestoday.org
Program
URL: http://www.demandcurestoday.org/treatment-innovations/funding-process

SYNOPSIS:  The Gateway supports innovative and unique clinical trials that have the potential to immediately impact the lives of cancer patients in a positive way. The Gateway provides support to investigators who pledge to collaborate with us and to seek treatments focused on saving the lives of today's cancer patients.

Deadline(s):


Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?94369


Sponsor: Case (Wendy Will) Cancer Fund, Inc.
Program Number: 60653
Title: Grant Program
E-mail: jmgrogan@wwccf.org
Program URL: http://www.wwccf.org

SYNOPSIS:  The sponsor supports innovative researchers.  The primary interest is, but not limited to, clinically-related research on cancer.  Applications for one year grants are considered with budgets of $30,000 or less.

Deadline(s): 04/01/2012
                  10/01/2012

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?60653


Sponsor: Department of the Army
Program Number: 92349
Title: Breast Cancer Research Program--Impact Award
E-mail: help@cdmrp.org
Web Site: http://cdmrp.army.mil/funding/bcrp.htm
Program URL: http://www07.grants.gov/search/search.do;jsessionid=LCYVTnBY1nryJGGpXFvQ7N1pG6HphFfRg6TvBR8d5js7pLLvnQ1y!-370087949?oppId=107873&mode=VIEW

SYNOPSIS:  The BCRP Impact Award supports research projects (from small- to large-scale) that specifically focus on scientific and clinical breast cancer issues, which, if successfully addressed, will revolutionize the understanding, prevention, and/or treatment of breast cancer and make major advances toward the goal of ending the disease. The BCRP particularly encourages applications that focus on poorly understood issues that are of critical significance in breast cancer, such as those related to prevention, susceptibility, recurrence, or metastasis. The proposed work must be based on sound overall research and fully supported by preliminary data and/or published reports.

Deadline(s): 08/15/2012

DEADLINE NOTE
Pre-application Submission Deadline is 5:00 p.m. Eastern time (ET), May 3, 2012. Invited Application Submission Deadline is 11:59 p.m. ET, August 15, 2012.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?92349


Sponsor: American Cancer Society, Inc.
Program Number: 15292
Title: Clinical Research Professor Awards
E-mail: david.ringer@cancer.org
Web Site: http://www.cancer.org/Research/ResearchProgramsFunding/FundingOpportunities/IndexofGrants/Professors/clinical-research-professor
Program URL: http://www.cancer.org/acs/groups/content/@researchadministration/documents/document/acspc-023670.pdf

SYNOPSIS:  The sponsor offers a limited number of grants to mid-career investigators who have made seminal contributions in the area of cancer control that have changed the direction of clinical, psychosocial, behavioral, health policy or epidemiologic cancer research.

Deadline(s): 08/01/2012

DEADLINE NOTE
Letters of Intent are due August 1, 2012. Full applications are due October 15 2012.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?15292


Sponsor: Multiple Myeloma Research Foundation
Program Number: 02741
Title: Biotech Investment Award
E-mail:
Web Site: http://www.themmrf.org
Program URL: http://www.themmrf.org/research-programs/for-academic-researchers/

SYNOPSIS:  The goal of this initiative is to drive and accelerate the development of innovative and effective treatments for myeloma.

Deadline(s): 08/28/2012

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?02741


Sponsor: Bayer HealthCare
Program Number: 06489
Title: Grants4Targets Initiative
E-mail: grants.for.targets@bayerhealthcare.com
Web Site: http://www.grants4targets.com/scripts/pages/en/index.php
Program URL: http://www.grants4targets.com/scripts/pages/en/process.php

SYNOPSIS:  To foster the translation of ideas into innovation the sponsor is looking for novel drug targets as a basis for the development of new therapeutic approaches. In addition, they are also interested in disease-related biomarkers in the therapeutic fields of Oncology, Gynecology, Cardiology, and Hematology.  The sponsor intends to offer the following different types of grants, depending on the specifics of the target and its development phase:   Support Grants of between ?5,000 to ?10,0000 in order to further advance research on targets that are at a very early stage of discovery; fixed grant approval letter; IP rights remain with the applicant.  Focus Grants of between ?10,000 and ?125,000 for more mature ideas, e.g. to address specific aspects of a target as a first step towards transferring it to the drug discovery process; fixed grant approval letter; IP rights remain with the applicant.

Deadline(s): 08/31/2012

DEADLINE NOTE
There are two deadlines each year, one in the Spring and one in Autumn.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?06489


Sponsor: Oncology Nursing Foundation/Society
Program Number: 64259
Title: Trish Greene Pain Assessment and Management Research Grant
E-mail: research@ons.org
Web Site: http://www.onsfoundation.org/apply/re
Program URL: http://www.onsfoundation.org/apply/re/TrishGreene

SYNOPSIS:  The sponsor provides a grant of up to $25,000 to promote oncology nursing research in the areas of pain assessment and pain management.

Deadline(s): 09/01/2012

DEADLINE NOTE
Letters of Intent Due: September 1, 2012; Application Deadline:
October 1, 2012

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?64259


Sponsor: Oncology Nursing Foundation/Society
Program Number: 21106
Title: Neuro-Oncology Nursing Research Grant
E-mail: research@ons.org
Web Site: http://www.ons.org
Program URL: http://www.onsfoundation.org/apply/re

SYNOPSIS:   Support is provided for a $25,000 neuro-oncology nursing research grant.

Deadline(s): 09/01/2012

DEADLINE NOTE
Required Letters of Intent are due September 1, 2012. Online Applications are due October 1, 2012.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?21106


Sponsor: Lymphoma Research Foundation
Program Number: 67393
Title: Two-Year Postdoctoral Fellowships (2013-2015)
E-mail: researchgrants@lymphoma.org
Web Site: http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=6330663
Program URL: http://www.lymphoma.org/atf/cf/%7Baaf3b4e5-2c43-404c-afe5-fd903c87b254%7D/FELLOWSHIP_RFP_2013_FINAL.PDF

SYNOPSIS:  The Lymphoma Research Foundation (LRF) seeks proposals for its 2-year Postdoctoral Fellowship Grant to support research, which may be laboratory- or clinic-based, with results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/or non-Hodgkin lymphoma.

Deadline(s): 09/03/2012

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?67393


Sponsor: Lymphoma Research Foundation
Program Number: 67395
Title: Three-Year Clinical Investigator Career Development Grant (2013-2016)
E-mail: researchgrants@lymphoma.org
Web Site: http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=6330663
Program URL: http://www.lymphoma.org/atf/cf/%7Baaf3b4e5-2c43-404c-afe5-fd903c87b254%7D/CDA_RFP_2013_FINAL.PDF

SYNOPSIS:  The Lymphoma Research Foundation (LRF) seeks proposals for its 3-year Clinical Investigator Career Develop Award Grant. The purpose of LRF's Clinical Investigator Career Development Award is to fund training of physician investigators who will participate in developing new therapeutics and diagnostic tools for lymphoma.

Deadline(s): 09/03/2012

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?67395


Sponsor: Conquer Cancer Foundation of ASCO
Program Number: 06440
Title: Career Development Award
E-mail: grants@ConquerCancerFoundation.org
Web Site: http://www.conquercancerfoundation.org/cancer-professionals/funding-opportunities/career-development-award
Program URL: http://www.conquercancerfoundation.org/sites/conquercancerfoundation.org/files/2013_cda_rfp_120524.pdf

SYNOPSIS: The sponsor provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. The total grant amount is $200,000 for a project period of three years.

Deadline(s): 09/27/2012

DEADLINE NOTE
The 2013 Career Development Award (CDA) online application opens on July 1, 2012 and applications are due September 27, 2012.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?06440


Sponsor: Skin Cancer Foundation
Program Number: 32017
Title: Research Grants Program
E-mail:
Web Site: http://www.skincancer.org
Program URL: http://www.skincancer.org/for-medical-professionals/research-grants/2013-research-grants

SYNOPSIS:  The Foundation funds basic research and clinical studies which address improved methods of prevention, detection, and treatment of skin cancer.  Researchers are invited to submit applications for one-year projects to be conducted within the Dermatology departments of medical institutions within the U.S.

Deadline(s): 10/05/2012

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?32017


Sponsor: American Cancer Society, Inc.
Program Number: 58690
Title: Research Scholar Grants in Cancer Control and Prevention: Health Policy and Health Services Research
E-mail: grants@cancer.org
Program URL: http://www.cancer.org/Research/ResearchProgramsFunding/FundingOpportunities/IndexofGrants/NewInitiatives/priority-focus-in-cancer-control-and-prevention-research-program-health-disparities-research

SYNOPSIS:  The sponsor provides support for research projects centered on health services and health policy research.

Deadline(s): 10/15/2012

DEADLINE NOTE
The sponsor's annual application deadlines are April 1 and October 15.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?58690


Sponsor: American Cancer Society, Inc.
Program Number: 05662
Title: Mentored Research Scholar Grant in Applied and Clinical Research
E-mail: grants@cancer.org
Web
Site: http://www.cancer.org/Research/ResearchProgramsFunding/FundingOpportunities/IndexofGrants/MentoredTrainingandCareerDevelopmentGrants/mentored-research
Program
URL: http://www.cancer.org/acs/groups/content/@researchadministration/documents/document/acspc-027414.pdf

SYNOPSIS:  Mentored Research Scholar Grants in Applied and Clinical Research  provide support for mentored research and training to full-time junior faculty, typically within the initial four years of their first independent appointment. The goal is for these beginning investigators to become independent researchers as either clinician scientists or cancer control and prevention researchers.

Deadline(s): 10/15/2012

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?05662


Sponsor: Memorial Sloan-Kettering Cancer Center
Program Number: 17050
Title: Clinical Fellowships-- Medical Genetics
E-mail:
Web Site: http://www.mskcc.org
Program URL: http://www.mskcc.org/education/fellowships/fellowship/medical-genetics

SYNOPSIS:  The New York-Presbyterian Hospital (NYPH) and Memorial Sloan-Kettering Cancer Center jointly offer an ACGME-accredited two-year training program in Medical Genetics. The program is designed to train physicians to diagnose, manage, and counsel patients with genetic disorders. 

Deadline(s):

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?17050


Sponsor: Memorial Sloan-Kettering Cancer Center
Program Number: 17059
Title: Clinical Fellowships -- Nuclear Oncology Fellowship
E-mail: wooda@mskcc.org
Web Site: http://www.mskcc.org
Program URL: http://www.mskcc.org/education/fellowships/fellowship/nuclear-oncology-fellowship

SYNOPSIS:  This fellowship is offered to provide extensive training in the therapeutic use of radioisotopes, positron emission tomography, and conventional nuclear medicine in patients with cancer.
Each fellow must actively participate in clinical research projects that are ongoing in the department; these include radiotherapy with novel immune constructs, as well as the use of specific PET tracers for metabolic imaging of human tumors. In addition, there will be an opportunity for basic instruction in biomathematics, imaging physics, radiochemistry, and medical oncology. 

Deadline(s):

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?17059


Sponsor: Memorial Sloan-Kettering Cancer Center
Program Number: 17193
Title: Palliative Medicine - Fellowship Training Programs
E-mail: HPMfellowship@mskcc.org
Web Site: http://www.mskcc.org
Program URL: http://www.mskcc.org/education/fellowships/fellowship/palliative-medicine

SYNOPSIS:  The Pain and Palliative Care Service in the Department of Medicine offers a one-year clinical fellowship in palliative medicine accredited by the Accreditation Council for Graduate Medical Education. Individuals who have completed a residency in internal medicine, family medicine, physical medicine and rehabilitation, psychiatry, neurology, anesthesiology, surgery, pediatrics, emergency medicine, radiology, or obstetrics and gynecology are eligible.
Physicians who have trained in internal medicine and have completed, or plan to complete, training in medical oncology are especially encouraged to apply. 
Deadline(s):

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?17193


Sponsor: Memorial Sloan-Kettering Cancer Center
Program Number: 17318
Title: Clinical Fellowships-- Pediatric Survivorship Fellowship
E-mail: wernerw@mskcc.org
Web Site: http://www.mskcc.org
Program URL: http://www.mskcc.org/education/fellowships/fellowship/pediatric-survivorship-fellowship

SYNOPSIS:  The sponsor offers a one-year program designed to train physicians to effectively evaluate and treat survivors of childhood and adolescent cancer.

Deadline(s):

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?17318


Sponsor: Memorial Sloan-Kettering Cancer Center
Program Number: 17321
Title: Pelvic Reconstruction Clinical Research Fellowship
E-mail: chid@mskcc.org
Program URL: http://www.mskcc.org/education/fellowships/fellowship/pelvic-reconstruction-clinical-research-fellowship-gynecology-service

SYNOPSIS:  The Pelvic Reconstructive Clinical Research fellowship is a one year position that exposes research fellows to the latest reconstructive techniques used following pelvic exonerative surgery.

Deadline(s):

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?17321


Sponsor: Memorial Sloan-Kettering Cancer Center
Program Number: 17336
Title: Clinical Fellowship Program in Psychosomatic Medicine and Psycho-Oncology
E-mail:
Web Site: http://www.mskcc.org/
Program URL: http://www.mskcc.org/education/fellowships/fellowship/clinical-fellowship-psychosomatic-medicine-and-psycho-oncology-acgme-number-4093531020

SYNOPSIS:  The overall purpose and goal of the Clinical Fellowship Training Program in Psychosomatic Medicine/Psycho-Oncology is to provide comprehensive postgraduate training of psychiatrists and psychologists in order to prepare them to become specialists in psychosomatic medicine in a unique oncology setting, while also providing training in disease management subspecialty areas offered at New York-Presbyterian/Weill Cornell Medical Center. 

Deadline(s): 11/30/2012

DEADLINE NOTE
Applications are accepted from July 1 through November 30 for positions starting the following July 1.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?17336


Sponsor: Memorial Sloan-Kettering Cancer Center
Program Number: 73512
Title: Clinical Fellowships--Psychosomatic Medicine and Psycho-Oncology
E-mail: chaparra@mskcc.org
Web Site: http://www.mskcc.org
Program URL: http://www.mskcc.org/education/fellowships/fellowship/clinical-fellowship-psychosomatic-medicine-and-psycho-oncology-acgme-number-4093531020

SYNOPSIS:  The sponsor offers one or two year clinical fellowships designed to provide training in Psychosomatic Medicine and Psycho-Oncology.
Deadline(s): 11/30/2012

DEADLINE NOTE
Applications are accepted from July 1 through November 30 for positions starting the following July 1.

Link to full program description: http://www.infoed.org/new_spin/spin_prog.asp?73512

Top of Page


Support UTMB | UTMB Home | Site Index | Privacy Policy | UTMB Healthcare

Copyright © 2014 University of Texas Medical Branch, Cancer Center.
Phone: 800.917.8906 • Fax: 409.747.1938 • cancer.center@utmb.edu
Cancer Center, 301 University Blvd, Galveston, TX 77555-1074